Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Company Description Sia is a next-generation, global management consulting group. Founded in 1999, we were born digital. Today our strategy and management capabilities are augmented by data science, enhanced by creativity and driven by responsibility. Were
Discover our galaxy Join the Future of Work ! Malt is Europes leading freelance marketplace, connecting over 1,000,000 talented freelancers with 100,000+ companies. Founded in 2013, were transforming how work gets done through our tech-powered, human-centered
Due to the highly confidential nature of the search, the identity of the company and exact location will be disclosed only to selected candidates at the appropriate stage of the process and subject to confidentiality. Beyond